In the fourth quarter of 2020 CordenPharma announced both an expansion of non-GMP capacity at its Center of Excellence for Peptide Process Development in Frankfurt, Germany, and a major increase in upstream capacity with the introduction of a new 3,000L Solid Phase Peptide Synthesis (SPPS) vessel in CordenPharma Colorado.   As the next step of its growth strategy, CordenPharma has added a second 100 cm high-pressure chromatography column at CordenPharma Colorado to accommodate the continuous gro...